Any dose adjustments must be made under the direct supervision of a qualified healthcare professional within an appropriate clinical framework
GIP stands for glucose-dependent insulinotropic polypeptide, another hormone released in the gut when we eat
When speaking with your doctor, it may be helpful to: Share your weight management history , including previous treatments, lifestyle interventions, and any underlying conditions such as type 2 diabetes, hypertension, or sleep apnoea Ask about currently approved options , such as orlistat (available on the NHS
The once-daily Wegovy pill demonstrated up to 17% average weight loss when used along with a reduced calorie diet and exercise
Semaglutide: Targets the GLP-1 pathway only Focuses on appetite regulation and fullness Tirzepatide: Targets both GLP-1 and GIP pathways May create a broader metabolic response Although this difference sounds technical, it can influence how patients respond to treatment